Sionna Therapeutics, Inc.

NASDAQ:SION

Biotechnology

Healthcare
$2.97 +1.85%

+$0.68 today

Market cap
$134.35M
Beta
1.29
P/E (TTM)
-19.7
EPS (TTM)
-$1.90
52W Low $13.81High $48.45

Volume 0.65M

Average 0.39M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$88.98M

FY 2025 · Annual

Net Income

-$75.27M

FY 2025 · Annual

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000
Cost of Revenue00668K647K
Gross Profit00(668K)(647K)
Gross Margin————
Research & Development34.61M40.63M57.29M60.26M
Selling, General & Admin6.77M9.71M13.27M28.72M
Operating Expenses41.37M50.33M69.89M88.34M
Depreciation & Amortization122K583K668K647K
EBITDA(40.12M)(46.68M)(61.02M)(74.62M)
EBITDA Margin————
Operating Income(41.37M)(50.33M)(70.56M)(88.98M)
Operating Margin————
Interest Income1.13M2.77M8.17M13.3M
Interest Expense0000
Other Income / Expenses1.13M3.07M8.87M13.71M
Income Before Tax(40.24M)(47.26M)(61.69M)(75.27M)
Pre-Tax Margin————
Income Tax Expense0000
Net Income(40.24M)(47.26M)(61.69M)(75.27M)
Net Margin————
EPS (Basic)(0.91)(1.07)(1.40)(1.88)
EPS (Diluted)(0.91)(1.07)(1.40)(1.88)
Weighted Avg Shares44.12M44.12M44.12M39.96M
Weighted Avg Shares (Diluted)44.12M44.12M44.12M39.96M

SION Earnings Waterfall · TTM

NASDAQ:SION · Revenue to Net Income

Key Ratios

EPS$-1.93
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-16.4
P/S Ratio0.0

Analysis

$0 of revenue converted into -$85.6M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.93, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13GSC 13G filingNov 9, 2026
SC 13D/ASC 13D/A filingSep 21, 2026
4Statement of changes in beneficial ownershipSep 21, 2026

How much revenue does SION generate?

Sionna Therapeutics, Inc. (SION) reported $0.00 of revenue in fiscal 2025.

Is SION profitable?

Sionna Therapeutics, Inc. (SION) reported -$75.27M of net income.